p-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1H)-isoquinolyl)ethyl]benzenesulphonamide | CAS 33456-68-7

Element: benzenesulphonamide isoquinolyl dimethyl dihydro methoxy dioxo ethyl

Page Content Identification Properties Suppliers Prices & Availability Get Quick Quote ☰

Identification Properties Suppliers Prices & Availability Get Quick Quote

C-S » Chemicals » dihydro-methoxy-dimethyl-dioxo-isoquinolyl-ethyl-benzenesulphonamide-PX2730393

Identification

p-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1H)-isoquinolyl)ethyl]benzenesulphonamide

CAS:

33456-68-7

EINECS:

251-529-0

Molecular Formula:

C₂₀H₂₂N₂O₅S

MDL:

Synonym:

benzenesulfonamide,4- 2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1h)-isoquinolinyl)ethyl ; benzenesulfonamide,4-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1h)-isoquinolinyl)ethyl]- ; p-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1h)isoquinolyl)ethyl]benzenesulphonamide ( forgliquidone ) ; p-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1h)isoquinoly)ethyl]benzenesulphonamide ; benzenesulfonamide,p-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1h)-isoquinolyl)ethyl]-(8ci) ; p-[2-[(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-1h-isoquinolin)-2-yl]ethyl]benzenesulfonamide ; lsoquinoline(intermediate of gliquidone) ; 4-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1h)-isoquinolinyl)ethyl]benzenesulfonamide ; p-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1h)-isoquinolyl)ethyl]benzenesulphonamide

Suppliers

Get Quick Quote

CAS equal suppliers

P-[2-(3,4-Dihydro-7-Methoxy-4,4-Dimethyl-1,3-Dioxo-2(1H)Isoquinoly)Ethyl]Benzenesulphonamide

Chemieliva Pharmaceutical Co., Ltd.

CP3220096600

P-[2-(3,4-Dihydro-7-Methoxy-4,4-Dimethyl-1,3-Dioxo-2(1H)Isoquinoly)Ethyl]Benzenesulphonamide

Leap Chem Co., Ltd

LC1656049680

P-[2-(3,4-Dihydro-7-Methoxy-4,4-Dimethyl-1,3-Dioxo-2(1H)Isoquinoly)Ethyl]Benzenesulphonamide

Skyrun Industrial Co., Ltd.

SI2484074520

P-[2-(3,4-Dihydro-7-Methoxy-4,4-Dimethyl-1,3-Dioxo-2(1H)Isoquinoly)Ethyl]Benzenesulphonamide

Finipharma Ltd

F1288025760